These genes were selected on the basis of methyl-CpG levels in their upstream regulatory regions shown in the MBD2-pulldown experiments and of their existence in previous reports of differential methylation in melanoma or cancer cells53, 65. This evidence concerns the gene MBD2 and melanoma.